FDA Inspection
The American National Red CrossThe American National Red Cross – FDA Inspection, Aug 8, 2023
Record Details
This FDA Inspection record concerns The American National Red Cross, with an inspection on August 8, 2023, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · f1ec8b52-1d45-42b0-9b87-2508f2e65cd4
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1216352
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of The American National Red Cross
7| Date | Classification | Office | Project area |
|---|---|---|---|
| February 9, 2026 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 10, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 10, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 9, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 2, 2013 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for The American National Red Cross
- FDA Inspection 1303552 - 2026-02-09
- FDA Inspection 1101370 - 2019-07-10
- FDA Inspection 1007197 - 2017-03-10
- FDA Inspection 951690 - 2015-11-09
- FDA Inspection 857246 - 2013-12-02
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.